Medical products company Abaxis (ABAX) finishes the day in the red, dropping -14.5% after...
Medical products company Abaxis (ABAX) finishes the day in the red, dropping -14.5% after reporting FQ1 earnings that missed expectations. International bookings took a hit due to timing issues with orders through its distributors. CEO Clint Severson summed up the quarter as "a period of investment for future growth."
From other sites
at CNBC.com (Sep 22, 2014)
at CNBC.com (Nov 15, 2013)
at CNBC.com (Jul 16, 2013)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs